Scientific work

Doç. Dr. Emir Çelik

58 publications. The source of the information is stated next to each publication.

Back to profile

  1. The most cited articles on cancer immunotherapy: An update study.

    PubMed, 2020

    PMID 32521924 5 citations (Europe PMC) Source: OpenAlex

  2. Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220918627 PMID 32299317 1 citation (Europe PMC) Source: OpenAlex

  3. Complete response after ceritinib treatment in non-small cell lung cancer in an elderly patient

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220919172 PMID 32340536 1 citation (Europe PMC) Source: OpenAlex

  4. KANSER HASTALARINDA UYKU KALİTESİNİ ETKİLEYEN FAKTÖRLER

    Namık Kemal Tıp Dergisi, 2020

    DOI 10.37696/nkmj.674879 Open-access full textSource: OpenAlex

  5. Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220964895 PMID 33040673 Source: OpenAlex

  6. Optic Neuritis Related to Atezolizumab Treatment in a Patient With Metastatic Non–Small-Cell Lung Cancer

    JCO Oncology Practice, 2019

    DOI 10.1200/jop.19.00438 PMID 31721624 11 citations (Europe PMC) Source: OpenAlex

  7. Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz449.007 Open-access full textSource: OpenAlex

  8. Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up

    Endocrine, 2018

    DOI 10.1007/s12020-018-1744-8 PMID 30206771 29 citations (Europe PMC) Source: OpenAlex